Variant report

Variant	esv2754467
Chromosome Location	chr16:79539799-79598399
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:14)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:79581170..79583871-chr16:79589118..79591243,2	K562	blood:
2	chr16:79589254..79592175-chr16:79597127..79599892,2	MCF-7	breast:
3	chr16:79581170..79583871-chr16:79589118..79591243,2	K562	blood:
4	chr16:79571976..79574892-chr16:79585503..79587633,3	K562	blood:
5	chr16:79571976..79574892-chr16:79585503..79587633,3	K562	blood:
6	chr16:79539560..79540080-chr2:183581054..183581554,2	Hela-S3	cervix:
7	chr16:79571754..79574549-chr16:79581664..79583931,2	K562	blood:
8	chr16:79542138..79545061-chr16:79546534..79548367,2	K562	blood:
9	chr16:79542821..79544888-chr16:79553986..79556215,2	MCF-7	breast:
10	chr16:79589254..79592175-chr16:79597127..79599892,2	MCF-7	breast:
11	chr16:79542821..79544888-chr16:79553986..79556215,2	MCF-7	breast:
12	chr16:79542138..79545061-chr16:79546534..79548367,2	K562	blood:
13	chr16:79571754..79574549-chr16:79581664..79583931,2	K562	blood:
14	chr16:79590048..79591563-chr16:79622856..79624638,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-WWOX-1	chr16:79549878-79550170	XLOC_011795
2	lnc-WWOX-1	chr16:79549878-79550190	ENSG00000261472.1

No data

Variant related genes	Relation type
ENSG00000077232	chromatin interactions

Extended variants
information (count: 3256 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:3256 , 50 per page) page: 1 2 3 4 5 6 7 ... 66

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs554996975	chr16:79539802-79539803	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs8049236	chr16:79539810-79539811	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs544163635	chr16:79539846-79539847	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs552375042	chr16:79539847-79539848	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs529582273	chr16:79539867-79539868	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs181937679	chr16:79539881-79539882	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs376398461	chr16:79539885-79539886	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs541659146	chr16:79539889-79539890	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs554164796	chr16:79539922-79539923	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs559649715	chr16:79539933-79539934	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs576149269	chr16:79539965-79539966	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs369965971	chr16:79539991-79539992	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs186563090	chr16:79540007-79540008	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs374342119	chr16:79540034-79540035	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs117276640	chr16:79540090-79540091	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs549689829	chr16:79540103-79540104	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs529935948	chr16:79540145-79540146	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs376146277	chr16:79540170-79540171	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs74481355	chr16:79540200-79540201	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs146836900	chr16:79540263-79540264	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs547195925	chr16:79540295-79540296	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs565736534	chr16:79540301-79540302	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs139219120	chr16:79540324-79540325	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs149436052	chr16:79540333-79540334	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs143801571	chr16:79540353-79540354	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs537464189	chr16:79540387-79540388	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs368679361	chr16:79540389-79540390	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs577621420	chr16:79540391-79540392	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs148090082	chr16:79540427-79540428	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs553576500	chr16:79540429-79540430	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs1862717	chr16:79540456-79540457	Weak transcription Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs1862716	chr16:79540470-79540471	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs74037335	chr16:79540497-79540498	Weak transcription Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs575701748	chr16:79540517-79540518	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs543025985	chr16:79540523-79540524	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs190624873	chr16:79540527-79540528	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs376616698	chr16:79540530-79540531	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs73583462	chr16:79540556-79540557	Weak transcription Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs559534782	chr16:79540607-79540608	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs370699878	chr16:79540632-79540633	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs141816544	chr16:79540638-79540639	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs548337371	chr16:79540684-79540685	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs200797584	chr16:79540736-79540737	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs570067207	chr16:79540832-79540833	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs537501469	chr16:79540837-79540838	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs373198726	chr16:79540851-79540852	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs146059536	chr16:79540894-79540895	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs535379481	chr16:79540911-79540912	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs553373497	chr16:79540952-79540953	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs374176639	chr16:79540967-79540968	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
small cell lung cancer	20016488	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Adrenocortical carcinoma	18281524	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Hypoplastic left heart syndrome	22349727	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:357 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:79539400-79539800	Enhancers	Fetal Muscle Trunk	muscle
2	chr16:79539400-79539800	Active TSS	Placenta	Placenta
3	chr16:79539400-79539800	Enhancers	Lung	lung
4	chr16:79539400-79540800	Active TSS	Adipose Nuclei	Adipose
5	chr16:79539400-79542000	Weak transcription	Psoas Muscle	Psoas
6	chr16:79539600-79539800	Enhancers	Primary monocytes fromperipheralblood	blood
7	chr16:79539600-79539800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
8	chr16:79539600-79539800	Enhancers	Right Atrium	heart
9	chr16:79539600-79540800	Active TSS	Fetal Muscle Leg	muscle
10	chr16:79539600-79543000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr16:79539800-79540400	Weak transcription	Spleen	Spleen
12	chr16:79539800-79541800	Weak transcription	Primary monocytes fromperipheralblood	blood
13	chr16:79539800-79542000	Weak transcription	Placenta	Placenta
14	chr16:79539800-79543200	Weak transcription	Lung	lung
15	chr16:79539800-79553000	Weak transcription	Right Atrium	heart
16	chr16:79540400-79540600	Enhancers	Spleen	Spleen
17	chr16:79540600-79543200	Weak transcription	Spleen	Spleen
18	chr16:79540800-79541800	Weak transcription	Adipose Nuclei	Adipose
19	chr16:79540800-79542400	Weak transcription	Fetal Muscle Leg	muscle
20	chr16:79541800-79543800	Enhancers	Adipose Nuclei	Adipose
21	chr16:79541800-79544000	Enhancers	Primary monocytes fromperipheralblood	blood
22	chr16:79542000-79542200	Enhancers	Brain Cingulate Gyrus	brain
23	chr16:79542000-79542200	Enhancers	Psoas Muscle	Psoas
24	chr16:79542000-79542400	Enhancers	H1 Cell Line	embryonic stem cell
25	chr16:79542000-79543200	Enhancers	Skeletal Muscle Female	skeletal muscle
26	chr16:79542000-79543800	Enhancers	Cortex derived primary cultured neurospheres	brain
27	chr16:79542000-79543800	Enhancers	Skeletal Muscle Male	skeletal muscle
28	chr16:79542000-79543800	Enhancers	Monocytes-CD14+_RO01746	blood
29	chr16:79542000-79544000	Enhancers	Breast Myoepithelial Primary Cells	Breast
30	chr16:79542000-79544000	Enhancers	Placenta	Placenta
31	chr16:79542200-79542400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr16:79542200-79542800	Weak transcription	Brain Cingulate Gyrus	brain
33	chr16:79542200-79543000	Weak transcription	Psoas Muscle	Psoas
34	chr16:79542200-79543600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
35	chr16:79542200-79543600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr16:79542200-79543800	Enhancers	Primary hematopoietic stem cells short term culture	blood
37	chr16:79542400-79542600	Enhancers	Fetal Muscle Leg	muscle
38	chr16:79542400-79542800	Weak transcription	H1 Cell Line	embryonic stem cell
39	chr16:79542400-79543400	Enhancers	Primary hematopoietic stem cells	blood
40	chr16:79542400-79543400	Enhancers	Brain Germinal Matrix	brain
41	chr16:79542400-79544000	Enhancers	Brain Anterior Caudate	brain
42	chr16:79542600-79543000	Weak transcription	Fetal Muscle Leg	muscle
43	chr16:79542600-79543200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
44	chr16:79542600-79543600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr16:79542600-79544000	Enhancers	Brain Hippocampus Middle	brain
46	chr16:79542600-79544000	Enhancers	Colon Smooth Muscle	Colon
47	chr16:79542800-79543000	Enhancers	Brain Angular Gyrus	brain
48	chr16:79542800-79543600	Enhancers	H1 Cell Line	embryonic stem cell
49	chr16:79542800-79543600	Enhancers	Brain Cingulate Gyrus	brain
50	chr16:79543000-79543600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links